For the six-month period ended June 30,

2025

2026

Net loss attributable to shareholders of Cellectis ($ in thousands)

(41,863

)

(39,584

)

Weighted average number of outstanding shares, used to calculate basic and diluted net result per share

100,231,292

100,587,696

Basic / Diluted net loss per share attributable to shareholders of Cellectis

Basic and diluted net loss per share attributable to shareholders of Cellectis ($ /share)

(0.42

)

(0.39

)

For the three-month period ended June 30,

2025

2026

Net loss attributable to shareholders of Cellectis ($ in thousands)

(23,736

)

(21,819

)

Weighted average number of outstanding shares, used to calculate basic and diluted net result per share

100,305,204

100,647,451

Basic / Diluted net loss per share attributable to shareholders of Cellectis

Basic and diluted net loss per share attributable to shareholders of Cellectis ($ /share)

(0.24

)

(0.22

)